Registration - Organization

Moderna Biopharma Canada Corporation / Stefan Raos, General Manager

Registration Information

Organization name: Moderna Biopharma Canada Corporation
Senior Officer Name: Stefan Raos, General Manager
Initial registration start date: 2023-11-02
Registration status: Active
Projected end date: No date provided
Registration number: 9939-5288

Associated Lobbying Activity Reports

Total number of Lobbying Activity Reports: 7

Lobbying Activity Reports - last 6 months: 3

Version 7 of 7 (2024-10-15 to present)

Registration versions:

Version 7 of 7 (2024-10-15 to present)

Subject Matter of the Lobbying Activities

Details Regarding the Identified Subject Matter

Will any of the lobbyists listed within this registration arrange a meeting between a public office holder and any other individual for the purpose of attempting to influence any of the matters listed below:

Yes

Specific Topics of Lobbying Communications	Intended Outcomes	Associated Subject Matters
Collaborate and advocate for continued funding of Moderna’s Spikevax Covid-19 Vaccine on publicly funded vaccine programs offered by PHSA and/or other Government and RHA programs.	Development, establishment, amendment or termination of any program, policy, directive or guideline of the government of British Columbia or a Provincial entity Awarding, amendment or termination of any contract, grant or financial benefit by or on behalf of the government of British Columbia or a Provincial entity	COVID-19, Finances and Budgets, Government Procurement, Health, Hospitals, Science and Technology, Senior Citizens
Communication with the BC Government and its stakeholders to advance a pro-innovation business environment for the life sciences sector. The aim is to foster an environment that encourages the development, trialing and adoption of innovative solutions in the life sciences sector, particularly those that leverage the groundbreaking mRNA technology.	Development, establishment, amendment or termination of any program, policy, directive or guideline of the government of British Columbia or a Provincial entity	Advanced Education, Economic Development and Trade, Health, Science and Technology
Ensure that any changes to pharmaceutical and vaccine funding support government reimbursement, which in turn enables choice and access to innovation (including mRNA innovation)	Development, establishment, amendment or termination of any program, policy, directive or guideline of the government of British Columbia or a Provincial entity Awarding, amendment or termination of any contract, grant or financial benefit by or on behalf of the government of British Columbia or a Provincial entity	Finances and Budgets, Government Procurement, Health, Science and Technology, Senior Citizens
Policy and program recommendations regarding the government's stimulus response measures related to COVID-19 and economic recovery.	Development, establishment, amendment or termination of any program, policy, directive or guideline of the government of British Columbia or a Provincial entity Awarding, amendment or termination of any contract, grant or financial benefit by or on behalf of the government of British Columbia or a Provincial entity	Advanced Education, COVID-19, Economic Development and Trade, Finances and Budgets, Government Procurement, Health, Hospitals, Science and Technology, Senior Citizens
Recommendations regarding job creation and growth of BC's knowledge-based economy. Business incentives for and/or barriers to investment in BC. Sharing of information on Moderna’s global mRNA research investment platform and opportunities for increased investment in BC.	Development, establishment, amendment or termination of any program, policy, directive or guideline of the government of British Columbia or a Provincial entity	Advanced Education, Economic Development and Trade, Health, Science and Technology
Upon availability of new vaccines – seek funding for the establishment of new vaccination programs.	Awarding, amendment or termination of any contract, grant or financial benefit by or on behalf of the government of British Columbia or a Provincial entity	Finances and Budgets, Health, Senior Citizens

BC Ministries/Provincial Entities

British Columbia Institute of Technology
Finance
Fraser Health Authority
Health
Health Employers Association of British Columbia
Innovate BC
Interior Health Authority
Jobs, Economic Development and Innovation
Member(s) of the BC Legislative Assembly
Northern Health Authority
Office of the Premier
Parliamentary Secretary for Rural Health
Parliamentary Secretary for Seniors' Services and Long-Term Care
Provincial Health Services Authority
University of British Columbia
Vancouver Coastal Health Authority
Vancouver Island Health Authority

Senior Officer Name and Position during the Period of this Registration

Stefan Raos, General Manager

Organization Contact Information

Moderna Biopharma Canada Corporation

Address:
155 Wellington St W
Suite 3130
Toronto, ON M5V 3H1
Canada

Telephone number: 647-503-0703

Description of Activities

Moderna is a biotech company focusing on vaccine technologies.

Gifts or benefits provided by the organization

Gifts or Benefits Provided to Public Officer Holders
Name	Gift or Benefit Description	Circumstance	Date Promised	Value Promised	Date Given	Value Given
No Records

Contributors to the Lobbying Activity

No person or organization contributed over $1000CDN, within the preceding 12 months, toward the lobbying activity on behalf of the organization that has a direct interest in the outcome of the lobbying activity.

Government Funding in the Last 12 Months

Received Government Funding

The Received Government Funding table below is not intended to be additive. Adding all of the entries together does not necessarily provide an accurate sum of all government funding received. There may be redundancy (reporting of the same funding more than once) caused by overlap in the "Date/Period Received" between 2 or more entries.

Source of Government Funding	Funding Received	Date/Period Received
Investissement Quebec	$9,060,350.00	2024-02-08
Investissement Quebec	$9,576,792.00	2024-08-15

View all received government funding history

Coalition Members Information

Moderna Biopharma Canada Corporation is not a coalition member.

Affiliates with a Direct Interest in the Outcome

Moderna Manufacturing Canada Corp.
- 405 Boulevard Armand-Frappier
  Laval, QC H7V 4B3
  Canada
ModernaTX, Inc.
- 325 Binney St
  Cambridge, MA 02142
  United States of America

Other Persons or Organizations with Direct Interests

The activities of Moderna Biopharma Canada Corporation are not controlled or directed by another person or organization with a direct interest in the outcome of this undertaking.

Lobbyists Employed by this Organization

Lobbyist

Contributions

Michelle Blake
Subscribes to a Code of Conduct: No
Former Public Office Holder in BC: No